Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
B01AC13
|
| gptkbp:CASNumber |
143653-53-6
|
| gptkbp:contraindication |
active internal bleeding
history of stroke recent major surgery |
| gptkbp:developedBy |
gptkb:Centocor
|
| gptkbp:drugClass |
gptkb:anticoagulant
|
| gptkbp:genericName |
abciximab
|
| gptkbp:hasMolecularFormula |
C6398H9932N1690O1996S52
|
| https://www.w3.org/2000/01/rdf-schema#label |
ReoPro
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Janssen_Biotech
|
| gptkbp:mechanismOfAction |
glycoprotein IIb/IIIa receptor inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
bleeding
thrombocytopenia |
| gptkbp:UNII |
QHL8QF6T1P
|
| gptkbp:usedFor |
percutaneous coronary intervention
prevention of cardiac ischemic complications |
| gptkbp:bfsParent |
gptkb:Centocor
|
| gptkbp:bfsLayer |
6
|